Follow
Enrico Galmozzi
Enrico Galmozzi
Verified email at unimi.it
Title
Cited by
Cited by
Year
Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential
E Monzani, F Facchetti, E Galmozzi, E Corsini, A Benetti, C Cavazzin, ...
European journal of cancer 43 (5), 935-946, 2007
7202007
Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
L Valenti, A Al‐Serri, AK Daly, E Galmozzi, R Rametta, P Dongiovanni, ...
Hepatology 51 (4), 1209-1217, 2010
6822010
Role of HER receptors family in development and differentiation
P Casalini, MV Iorio, E Galmozzi, S Ménard
Journal of cellular physiology 200 (3), 343-350, 2004
3362004
HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease
L Valenti, AL Fracanzani, E Bugianesi, P Dongiovanni, E Galmozzi, ...
Gastroenterology 138 (3), 905-912, 2010
3302010
I148M patatin‐like phospholipase domain‐containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease
L Valenti, A Alisi, E Galmozzi, A Bartuli, B Del Menico, A Alterio, ...
Hepatology 52 (4), 1274-1280, 2010
3222010
Patatin‐like phospholipase domain‐containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C
L Valenti, MG Rumi, E Galmozzi, A Aghemo, B Del Menico, S De Nicola, ...
Hepatology 53 (3), 791-799, 2011
2952011
Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B
F Lebossé, B Testoni, J Fresquet, F Facchetti, E Galmozzi, M Fournier, ...
Journal of hepatology 66 (5), 897-909, 2017
1532017
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4
S De Nicola, A Aghemo, M Grazia Rumi, E Galmozzi, L Valenti, ...
Hepatology 55 (2), 336-342, 2012
1092012
Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease
L Valenti, E Canavesi, E Galmozzi, P Dongiovanni, R Rametta, ...
Journal of hepatology 53 (5), 927-933, 2010
702010
Cancer stem cells and therapeutic perspectives
E Galmozzi, F Facchetti, CAM Porta
Current medicinal chemistry 13 (6), 603-607, 2006
662006
Homozygosity for the PNPLA3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
L Valenti, A Al Serri, AK Daly, E Galmozzi, R Rametta, P Dongiovanni, ...
JOURNAL OF HEPATOLOGY 52 (S1), S57-S57, 2010
632010
Synthesis, characterization and transfection activity of new saturated and unsaturated cationic lipids
S Arpicco, S Canevari, M Ceruti, E Galmozzi, F Rocco, L Cattel
Il Farmaco 59 (11), 869-878, 2004
622004
Hepatic fat—genetic risk score predicts hepatocellular carcinoma in patients with cirrhotic HCV treated with DAAs
E Degasperi, E Galmozzi, S Pelusi, R D’Ambrosio, R Soffredini, M Borghi, ...
Hepatology 72 (6), 1912-1923, 2020
572020
Hepatitis delta virus and hepatocellular carcinoma: an update
R Romeo, A Petruzziello, EI Pecheur, F Facchetti, R Perbellini, ...
Epidemiology & Infection 146 (13), 1612-1618, 2018
492018
Systematic review with meta‐analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon‐therapy in hepatitis B infection?
E Galmozzi, M Vigano, P Lampertico
Alimentary pharmacology & therapeutics 39 (6), 569-578, 2014
482014
Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy
PJ Clark, A Aghemo, E Degasperi, E Galmozzi, TJ Urban, DM Vock, ...
Journal of viral hepatitis 20 (12), 858-866, 2013
462013
Expression of Concern: HER2 signaling enhances 5′ UTR‐mediated translation of c‐Myc mRNA
E Galmozzi, P Casalini, MV Iorio, B Casati, C Olgiati, S Ménard
Journal of cellular physiology 200 (1), 82-88, 2004
432004
p53-dependent downregulation of metastasis-associated laminin receptor
M Modugno, E Tagliabue, E Ardini, V Berno, E Galmozzi, M De Bortoli, ...
Oncogene 21 (49), 7478-7487, 2002
402002
The variant hepatocyte nuclear factor 1 activates the P1 promoter of the human α-folate receptor gene in ovarian carcinoma
A Tomassetti, F Mangiarotti, M Mazzi, S Sforzini, S Miotti, E Galmozzi, ...
Cancer research 63 (3), 696-704, 2003
352003
The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent
R D’Ambrosio, A Aghemo, R De Francesco, MG Rumi, E Galmozzi, ...
International journal of molecular sciences 15 (5), 7213-7224, 2014
332014
The system can't perform the operation now. Try again later.
Articles 1–20